COVID-19: Laboratory Updates – Biosafety Guidelines

On March 13, 2020, CDC updated the Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) page on the Information for Laboratories website. The revisions include recommendations for: Following Standard Precautions when handling all clinical specimens Using automated instruments and analyzers Point-of-care testing (POCT) Using EPA-registered disinfectants with label…

Read more

FDA FAQ on Diagnostic Testing for SARS-CoV-2

On March 10, 2020, the Food and Drug Administration (FDA) posted answers to frequently asked questions (FAQs) on Diagnostic Testing for SARS-CoV-2. This LOCS message is to raise awareness about these FDA FAQs among clinical laboratories that could potentially be asked to perform testing. Topics covered include information on Confirmatory testing for presumptive positive results…

Read more

SURVEY ACTIVITY RESUMES WITH FOCUS ON INFECTION PREVENTION AND CONTROL

CMS announced on March 5, 2020 that the majority of deemed status surveys would be suspended due to the threat of COVID-19. This policy has been revised to allow hospital, CAH, and ASC surveys performed by HFAP and other accrediting organizations to resume. The four accreditation organizations (AO) with deeming authority for hospitals (HFAP, DNV,…

Read more